Found: 11
Select item for more details and to access through your institution.
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01746
- By:
- Publication type:
- Article
Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. e579, doi. 10.1016/j.clml.2021.02.008
- By:
- Publication type:
- Article
Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma.
- Published in:
- Transfusion, 2023, v. 63, n. 11, p. 2131, doi. 10.1111/trf.17566
- By:
- Publication type:
- Article
Analysis of stem cell collections in adult patients with Ewing sarcoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Two rare cases of bronchus-associated lymphoid tissue lymphoma successfully treated with rituximab-bendamustine.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.775313
- By:
- Publication type:
- Article
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.737645
- By:
- Publication type:
- Article
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1625, doi. 10.3390/cancers11111625
- By:
- Publication type:
- Article
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 741, doi. 10.2147/OTT.S45459
- By:
- Publication type:
- Article